Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy

Wei Chun Chen; Ting Chang Chang; Hung Hsueh Chou

doi:10.1016/j.bj.2022.01.012

Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy

Wei Chun Chen, Ting Chang Chang, Hung Hsueh Chou^*

^*此作品的通信作者

研究成果: 期刊稿件 › 快報 › 同行評審

1 引文斯高帕斯（Scopus）

原文	英語
頁（從 - 到）	849-850
頁數	2
期刊	Biomedical Journal
卷	45
發行號	5
DOIs	https://doi.org/10.1016/j.bj.2022.01.012
出版狀態	已出版 - 10 2022

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.bj.2022.01.012

其它文件與鏈接

Link to publication in Scopus

引用此

@article{7808c4efead446969815be85315fecc5,

title = "Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy",

keywords = "CA-125, HIPEC, Hyperthermic intraperitoneal chemotherapy, Ovarian cancer, Renal failure",

author = "Chen, {Wei Chun} and Chang, {Ting Chang} and Chou, {Hung Hsueh}",

year = "2022",

month = oct,

doi = "10.1016/j.bj.2022.01.012",

language = "英语",

volume = "45",

pages = "849--850",

journal = "Biomedical Journal",

issn = "2319-4170",

publisher = "Elsevier B.V.",

number = "5",

}

TY - JOUR

T1 - Reply

T2 - Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy

AU - Chen, Wei Chun

AU - Chang, Ting Chang

AU - Chou, Hung Hsueh

PY - 2022/10

Y1 - 2022/10

KW - CA-125

KW - HIPEC

KW - Hyperthermic intraperitoneal chemotherapy

KW - Ovarian cancer

KW - Renal failure

UR - http://www.scopus.com/inward/record.url?scp=85141697632&partnerID=8YFLogxK

U2 - 10.1016/j.bj.2022.01.012

DO - 10.1016/j.bj.2022.01.012

M3 - 快报

C2 - 35065283

AN - SCOPUS:85141697632

SN - 2319-4170

VL - 45

SP - 849

EP - 850

JO - Biomedical Journal

JF - Biomedical Journal

IS - 5

ER -